Your Health Plan:
Your Health Plan:
Not SelectedDARZALEX FASPRO (daratumumab and hyaluronidase (human recombinant)) is a biologic prescription drug for treatment of Amyloidosis. DARZALEX FASPRO is a combination of cd38-directed cytolytic antibody and endoglycosidase. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $10500-12600.
Patient Assistance Prorgams and Coupons are found:
No other option is found for DARZALEX FASPRO